PDLI: PDL BioPharma, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
1993	11.875	24.25	12.375	104.21%
1994	24.25	15.75	-8.50	-35.05%
1995	15.75	23.125	7.375	46.83%
1996	23.125	36.50	13.375	57.84%
1997	36.50	40.00	3.50	9.59%
1998	40.00	23.125	-16.875	-42.19%
1999	23.125	70.00	46.875	202.70%
2000	70.00	173.75*	103.75	148.21%
2001	86.875	65.60*	-21.275	-24.49%
2002	32.80	8.50	-24.30	-74.09%
2003	8.50	17.90	9.40	110.59%
2004	17.90	20.66	2.76	15.42%
2005	20.66	28.42	7.76	37.56%
2006	28.42	20.14	-8.28	-29.13%
2007	20.14	17.52	-2.62	-13.01%
2008	17.52	6.18	-11.34	-64.73%
2009	6.18	6.86	0.68	11.00%
2010	6.86	6.23	-0.63	-9.18%
2011	6.23	6.20	-0.03	-0.48%
2012	6.20	7.04	0.84	13.55%
2013	7.04	8.44	1.40	19.89%
2014	8.44	7.71	-0.73	-8.65%
2015	7.71	3.54	-4.17	-54.09%
2016	3.54	2.12	-1.42	-40.11%
2017	2.12	2.74	0.62	29.25%
2018	2.74	2.90	0.16	5.84%
2019	2.90	3.245	0.345	11.90%
2020	3.245	3.88012*	0.63512	19.57%

*The 2000 ending price for PDL BioPharma has been adjusted for a 2 for 1 stock split.
*The 2001 ending price for PDL BioPharma has been adjusted for a 2 for 1 stock split.
*In 2020, PDL BioPharma completed its spinoff of LENSAR, Inc. (LNSR). PDLI shareholders received .075879 shares of LNSR for every share of PDLI held. In addition, PDLI entered a dissolution process, at the end of 2020 the shares were valued at $3.33 per share.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).